Colgate-Palmolive Company

(New York Stock Exchange)
Back to all articles
Bullish +62

Colgate-Palmolive (CL) Expected to Release Earnings on Friday

AI-generated analysis

πŸ“… Colgate-Palmolive is set to release Q2 2026 earnings before market open on Friday, July 31st.

πŸ’° Analysts expect EPS of $0.9470 and revenue of $5.3563 billion for the upcoming quarter.

πŸ“ˆ The company previously beat estimates in May with $0.97 EPS and $5.32 billion in revenue.

🏒 Market cap stands at $72.00 billion with a P/E ratio of 35.01 and a beta of 0.33.

πŸ“Š Revenue grew 8.4% year-over-year, reaching $5.32 billion in the last reported quarter.

🎯 The consensus analyst target price is $97.82 with an average rating of Moderate Buy.

πŸ”Ό UBS Group raised its price target to $106.00 and reaffirmed a buy rating recently.

πŸ“‰ Wall Street Zen lowered the rating from buy to hold in late March.

🏦 Institutional ownership is high at 80.41% with major funds increasing stakes significantly.

πŸš€ Amundi grew its stake by 41.6%, while Two Sigma raised holdings by 360.9%.

Bullish Signals
  • The company recently beat earnings estimates with $0.97 EPS compared to a consensus of $0.94.
  • Revenue exceeded expectations at $5.32 billion versus the forecasted $5.22 billion.
  • UBS Group increased its price target to $106.00 and maintained a buy rating on Thursday, July 16th.
  • Deutsche Bank Aktiengesellschaft restated a buy rating with a $99.00 price target in May.
  • Amundi significantly increased its stake by 41.6% to own over 6.2 million shares valued at nearly $488 million.
  • Two Sigma Investments LP raised its position by 360.9%, now holding over 2.1 million shares worth approximately $170 million.
  • The Canada Pension Plan Investment Board boosted its holdings by 392.8% in the second quarter.
  • Revenue demonstrated solid growth of 8.4% on a year-over-year basis during the last reported quarter.
Risk Factors
  • Wall Street Zen lowered its rating from buy to hold in late March, indicating some caution among analysts.
  • The stock trades at a high P/E ratio of 35.01 and a PEG ratio of 4.83, suggesting potential valuation concerns relative to growth.
Full Analysis
Colgate-Palmolive (NYSE:CL) is scheduled to release its Q2 2026 earnings results before the market opens on Friday, July 31st. Analysts currently project earnings per share of $0.9470 and revenue of $5.3563 billion for the quarter. The company previously reported strong results in May, beating consensus estimates with EPS of $0.97 versus an expected $0.94 and revenue of $5.32 billion against a forecast of $5.22 billion. The stock currently trades at $89.98 with a market capitalization of $72.00 billion. Key valuation metrics include a price-to-earnings ratio of 35.01, a PEG ratio of 4.83, and a beta of 0.33. The company maintains a net margin of 10.04% and a return on equity of 386.76%, with revenue growing 8.4% year-over-year. Analysts have set an average consensus target price of $97.82 based on data from MarketBeat. Recent analyst activity shows mixed but generally positive sentiment, with UBS Group raising its target price to $106.00 and Deutsche Bank maintaining a buy rating at $99.00, though Wall Street Zen recently downgraded the stock to a hold. Institutional ownership remains robust at 80.41%, with significant stake increases from major funds including Amundi, Two Sigma Investments LP, and the Canada Pension Plan Investment Board during recent quarters.